The Warrants. Each Warrant shall entitle the holder to purchase one share of Common Stock at an exercise price of $6.00, subject to adjustment. The Warrants are exercisable at any time during the five year-period commencing on the effective date of the Registration Statement, as defined in Paragraph 2(a) herein (the "Effective Date"), subject to prior redemption by the Company. The Shares of Common Stock issuable upon the exercise of the Warrants are hereinafter referred to as the "Warrant Shares." The Warrants will be redeemable at a price of $0.10 per Warrant, commencing twelve (12) months after the Effective Date, or earlier with the prior written consent of the Underwriter, upon at least 30 days prior written notice provided that the closing bid price of the Common Stock (or closing sales price if listed on an exchange or on a reporting system that provides last sales prices) for twenty (20) consecutive trading days ending on the third day prior to the date on which notice of redemption is given, shall exceed $7.50 per share, subject to the right of the holder to exercise his purchase rights thereunder until redemption.
The Warrants. Subject to the terms and conditions of this Agreement, each Investor agrees, severally, to purchase and the Company agrees to issue to each Investor at the Closing a Warrant in the form of Exhibit B to purchase shares of Common Stock of the Company as set forth in the Warrant and exercisable at price set forth in the Warrant. The securities for which the Warrants are exercisable into are referred to as the “Warrant Stock”.
The Warrants. Matec has also authorized the issuance and sale to the Purchaser of Matec's Common Stock Purchase Warrants for the purchase (subject to adjustment as provided therein) of 85,000 shares of Matec's Common Stock. The Common Stock Purchase Warrants shall be substantially in the form set forth in EXHIBIT 1.02 hereto and are herein referred to individually as a "Warrant" and collectively as the "Warrants", which terms shall also include any warrants delivered in exchange or replacement therefor.
The Warrants. Subject to the terms and conditions of this Agreement, the Investor agrees to purchase and the Company agrees to issue to the Investor at the Closing a Warrant in the form of Exhibit A to purchase 330,000 shares of Common Stock of the Company exercisable at $1.25 per share. The securities for which the Warrants are exercisable into are referred to as the "Warrant Common".
The Warrants. The number of Warrants to be issued shall equal one-half of (i) the principal amount of the Convertible Debentures issued at Closing divided by (ii) the Market Price on the Trading Day immediately prior to the Closing Date. The exercise price of such Warrants shall be 115% of the closing bid price for the Common Stock on the Principal Market on the Trading Day immediately prior to the Closing Date. Two-thirds of the Warrants shall be immediately exercisable upon issuance. The remaining one-third of each Lender's Warrants shall only become exercisable if the Convertible Debentures have not been redeemed in accordance with their terms on or before the 100th day after the Closing Date.
The Warrants. At the Closing, the Company shall issue and deliver Common Stock purchase warrants (the "Warrants") entitling the Purchasers to purchase, on the terms and conditions set forth in Exhibit B hereto, an aggregate of 31 shares of Common Stock for each share of Series F Preferred Stock at a price per share equal to the initial Conversion Price (as defined in the Certificate of Designation attached hereto as Exhibit A) (the "Warrant Exercise Price").
The Warrants. Subject to the terms and conditions of this Agreement, the Company hereby issues and delivers to the Warrantholder a warrant, substantially in the form of Exhibit A hereto, to purchase 328,084 shares of fully paid and nonassessable Common Stock at a price per share equal to $19.05 (the "EXERCISE PRICE").
The Warrants. The Warrants to be issued and sold by the Company hereunder, when executed and delivered pursuant to the terms of this Agreement, will be duly authorized, executed and delivered by the Company and will conform to the descriptions thereof in the Registration Statement, the Pricing Disclosure Package and the Prospectus.
The Warrants. At the Closing, the Company shall issue (a) to JNC, a Common Stock purchase warrant, in the form of Exhibit D (the "JNC Warrant"), pursuant to which JNC shall have the right at any time and from time to time thereafter through the second anniversary of the date of issuance thereof, to acquire 50,000 shares of Common Stock at an exercise price per share equal to 110% of the Market Price on the Closing Date and (b) to DSF, a Common Stock purchase warrant, in the form of Exhibit D (the "DSF Warrant," and, collectively with the JNC Warrant, the "Warrants"), pursuant to which DSF shall have the right at any time and from time to time thereafter through the second anniversary of the date of issuance thereof, to acquire 10,000 shares of Common Stock at an exercise price per share equal to 110% of the Market Price on the Closing Date.